Sensus Healthcare, Inc.
General ticker "SRTS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $62.4M (TTM average)
Sensus Healthcare, Inc. does not follow the US Stock Market performance with the rate: -25.6%.
Estimated limits based on current volatility of 2.3%: low 2.76$, high 2.89$
Factors to consider:
- Total employees count: 60 (+11.1%) as of 2025
- US accounted for 92.3% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Inadequate reimbursement, Customer concentration, Market competition, Regulatory and compliance, Intellectual property risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.03$, 4.76$]
- 2026-12-31 to 2027-12-31 estimated range: [1.80$, 4.27$]
Financial Metrics affecting the SRTS estimates:
- Positive: with PPE of -8.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of 0.85 <= 2.37
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -12.70
Short-term SRTS quotes
Long-term SRTS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $24.41MM | $41.81MM | $27.48MM |
| Operating Expenses | $24.79MM | $33.72MM | $37.79MM |
| Operating Income | $-0.38MM | $8.09MM | $-10.31MM |
| Non-Operating Income | $1.03MM | $0.93MM | $0.68MM |
| R&D Expense | $3.68MM | $4.22MM | $7.78MM |
| Income(Loss) | $0.65MM | $9.02MM | $-9.62MM |
| Taxes | $0.17MM | $2.38MM | $-1.91MM |
| Net Income(Loss)* | $0.48MM | $6.65MM | $-7.72MM |
| Stockholders Equity | $48.84MM | $55.83MM | $48.10MM |
| Inventory | $11.86MM | $10.10MM | $14.56MM |
| Assets | $53.71MM | $62.16MM | $53.04MM |
| Operating Cash Flow | $-2.15MM | $-0.83MM | $0.53MM |
| Capital expenditure | $0.23MM | $0.28MM | $0.20MM |
| Investing Cash Flow | $-0.19MM | $-0.28MM | $-0.20MM |
| Financing Cash Flow | $-0.04MM | $0.01MM | $-0.30MM |
| Earnings Per Share** | $0.03 | $0.41 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.